Drugs / Control Rx
Trials 0
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT05768503 Comparator | Mar 2023 → Jan 2026 overdue | colorectal cancer | Sun Yat-sen University | Recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Control Rx | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05768503 ↗ |
| Route | Intravenous | “5-fluorouracil 400 mg/m2 IV +2400 mg/m2 CIV Q2W” NCT05768503 ↗ |